美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

First Tracks Biotherapeutics Inc

17.18

+0.42002.51%

盤後：17.180.00000.00%16:10 EDT

成交量：31.85萬

成交額：549.54萬

市值：5.97億

市盈率：-3.54

高：18.10

開：17.04

低：16.80

收：16.76

52周最高：26.80

52周最低：14.79

股本：3,474.88萬

流通股本：3,474.88萬

量比：0.85

換手率：0.92%

股息：- -

股息率：- -

每股收益(TTM):-4.8542

淨資產收益率：-48.91%

總資產收益率：-28.97%

市淨率：2.32

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

First Tracks Biotherapeutics公布2026年第一季度財務業績並更新業務進展

First Tracks Biotherapeutics公司：售股股東或可出售高達10.5股普通股 - SEC文件披露

美國研究綜述-Alphabet、高露潔-棕欖、Welltower

Piper Sandler首予First Tracks Biotherapeutics增持評級目標價54美元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/TRAX"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TRAX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TRAX\",,,,,undefined,":{"symbol":"TRAX","market":"US","secType":"STK","nameCN":"First Tracks Biotherapeutics Inc","latestPrice":17.18,"timestamp":1779480000000,"preClose":16.76,"halted":0,"volume":318536,"hourTrading":{"tag":"盘后","latestPrice":17.18,"preClose":17.18,"latestTime":"16:10 EDT","volume":5578,"amount":95830.04,"timestamp":1779480605159,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.025059665871121607,"floatShares":34748800,"shares":34748800,"eps":-4.854211,"marketStatus":"休市中","change":0.42,"latestTime":"05-22 16:00:00 EDT","open":17.04,"high":18.1,"low":16.8,"amount":5495357,"amplitude":0.077566,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.854211,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1779782400000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":16.76,"preHourTrading":{"tag":"盘前","latestPrice":16.65,"preClose":16.76,"latestTime":"07:57 EDT","volume":35,"amount":582.75,"timestamp":1779451041766,"change":-0.11,"changeRate":-0.006563,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":17.18,"preClose":17.18,"latestTime":"16:10 EDT","volume":5578,"amount":95830.04,"timestamp":1779480605159,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.8519761737224184,"impliedVol":0.6995,"impliedVolPercentile":0.5},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TRAX\",,,,,undefined,":{"symbol":"TRAX","floatShares":34748800,"roa":"-28.97%","roe":"-48.91%","lyrEps":0,"volumeRatio":0.8519761737224184,"shares":34748800,"dividePrice":0,"high":18.1,"amplitude":0.077566,"preClose":16.76,"low":16.8,"week52Low":14.79,"pbRate":"2.32","week52High":26.8,"institutionHeld":0,"latestPrice":17.18,"eps":-4.854211,"divideRate":0,"volume":318536,"delay":0,"ttmEps":-4.854211,"open":17.04,"prevYearClose":20,"prevWeekClose":16.9,"prevMonthClose":23.27,"prevQuarterClose":20,"fiveDayClose":16.9,"twentyDayClose":18.16},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TRAX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TRAX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TRAX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":6,"updateTime":1777867200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TRAX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TRAX","date":"2026-05-22","current":-3.539195,"percent":0.9,"low":-4.945978,"twenty":-4.299486,"median":-3.855938,"eighty":-3.664859,"high":-3.330098,"avg":-3.986057,"sd":0.449538,"marketCap":584796305},"quantilePoints":[{"date":"2026-04-24","current":-3.975194,"twenty":-3.975194,"median":-3.975194,"eighty":-3.975194,"marketCap":660227979},{"date":"2026-05-01","current":-4.868566,"twenty":-4.868566,"median":-4.085034,"eighty":-3.799448,"marketCap":808605530},{"date":"2026-05-08","current":-3.728313,"twenty":-4.68236,"median":-4.236719,"eighty":-3.799448,"marketCap":619224346},{"date":"2026-05-15","current":-3.799448,"twenty":-4.433387,"median":-4.031683,"eighty":-3.799448,"marketCap":631038952},{"date":"2026-05-22","current":-3.452672,"twenty":-4.299486,"median":-3.855938,"eighty":-3.664859,"marketCap":584796305}],"updateTime":1779660825115},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TRAX\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1102003350","title":"First Tracks Biotherapeutics公布2026年第一季度財務業績並更新業務進展","url":"https://stock-news.laohu8.com/highlight/detail?id=1102003350","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102003350?lang=zh_tw&edition=fundamental","pubTime":"2026-05-15 04:16","pubTimestamp":1778789777,"startTime":"0","endTime":"0","summary":"First Tracks Biotherapeutics Inc. 近日公布了其截至2026年第一季度的财务业绩，并向市场同步更新了公司最新的业务动态。此次发布涵盖了公司在关键研发项目上的推进情况、管线布局的调整以及未来的战略规划，旨在为投资者提供全面的运营视角。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137960030","title":"First Tracks Biotherapeutics公司：售股股東或可出售高達10.5股普通股 - SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1137960030","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137960030?lang=zh_tw&edition=fundamental","pubTime":"2026-05-09 04:40","pubTimestamp":1778272801,"startTime":"0","endTime":"0","summary":"根据提交给美国证券交易委员会的一份文件显示，First Tracks Biotherapeutics Inc的现有售股股东，可能将出售高达10.5股公司普通股。\n这份文件揭示了股东潜在的股份出售计划，相关信息已按监管要求进行备案。具体细节可在相关SEC文件中查阅。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632818936","title":"美國研究綜述-Alphabet、高露潔-棕欖、Welltower","url":"https://stock-news.laohu8.com/highlight/detail?id=2632818936","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632818936?lang=zh_tw&edition=fundamental","pubTime":"2026-05-04 15:35","pubTimestamp":1777880141,"startTime":"0","endTime":"0","summary":"美国研究综述-Alphabet、高露洁-棕榄、Welltower路透5月4日 - 周一，华尔街的证券分析师们调整了多家在美国上市公司的评级和目标股价，其中包括Alphabet、高露洁-棕榄和Welltower。股票条目按字母顺序排列。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nL4T41H0EI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AAPY","AMZN","ESS","MLM","FICO","AMGN","CNC","DECK","FTAI","BTSG","MSFT","BOBS","BLDR","CL","KEX","FLS","GDDY","AX","CHD","CORZ","DAR","AAPB","AMZZ","AAPL","AMZY","CSGP","EL","ESPR","TRAX","AMZU","AAPX","DAVE","HSY","ACA","SAM","APLY","CAH","AAPD","LEA","MTCH","META","CBOE","ETSY","GOOGL","AAPW","WELL","AXSM","AMP","AAPU","MTZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166118707","title":"Piper Sandler首予First Tracks Biotherapeutics增持評級 目標價54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1166118707","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166118707?lang=zh_tw&edition=fundamental","pubTime":"2026-05-04 11:36","pubTimestamp":1777865787,"startTime":"0","endTime":"0","summary":"投行Piper Sandler首次覆盖生物技术公司First Tracks Biotherapeutics，给予\"增持\"评级，并设定54美元的目标股价。\n该评级反映出分析师对该公司研发管线前景的乐观预期。目标价的设定基于对其创新疗法的估值评估。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TRAX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":7,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/TRAX\",params:#limit:6,delay:false,,,undefined,":[]}}